Investing in the Future of Precision Cancer Medicine

Developing a first-in-class, 3rd generation Polo-like Kinase 1 (PLK1) Inhibitor to treat leukemias, lymphomas
and solid tumor cancers

19th Annual Rodman & Renshaw Global Investment Conference
September 12, 2017
5:05pm - 5:30pm EDT
Lotte New York Palace

Trovagene CEO, Bill Welch, will present an overview of the Company at the 19th Annual Rodman & Renshaw Gloabl Investment Conference on Tuesday, September 12th, at 5:05 pm EDT at the Lotte New York Palace in New York City, NY. The presentation will be webcast live. To access the webcast, please visit  The webcast replay will remain available for 90 days following the live presentation.